151 related articles for article (PubMed ID: 38713861)
21. T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy.
Duan Z; Ho M
Mol Cancer Ther; 2021 Sep; 20(9):1533-1541. PubMed ID: 34172530
[TBL] [Abstract][Full Text] [Related]
22. LncACTdb 2.0: an updated database of experimentally supported ceRNA interactions curated from low- and high-throughput experiments.
Wang P; Li X; Gao Y; Guo Q; Wang Y; Fang Y; Ma X; Zhi H; Zhou D; Shen W; Liu W; Wang L; Zhang Y; Ning S; Li X
Nucleic Acids Res; 2019 Jan; 47(D1):D121-D127. PubMed ID: 30476305
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive manually curated protein-protein interaction database for the Death Domain superfamily.
Kwon D; Yoon JH; Shin SY; Jang TH; Kim HG; So I; Jeon JH; Park HH
Nucleic Acids Res; 2012 Jan; 40(Database issue):D331-6. PubMed ID: 22135292
[TBL] [Abstract][Full Text] [Related]
24. Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers.
Chen L; Qiao D; Wang J; Tian G; Wang M
Immunol Lett; 2019 Dec; 216():51-62. PubMed ID: 31597088
[TBL] [Abstract][Full Text] [Related]
25. Large-scale template-based structural modeling of T-cell receptors with known antigen specificity reveals complementarity features.
Shcherbinin DS; Karnaukhov VK; Zvyagin IV; Chudakov DM; Shugay M
Front Immunol; 2023; 14():1224969. PubMed ID: 37649481
[TBL] [Abstract][Full Text] [Related]
26. Designing TCR for cancer immunotherapy.
Voss RH; Kuball J; Theobald M
Methods Mol Med; 2005; 109():229-56. PubMed ID: 15585925
[TBL] [Abstract][Full Text] [Related]
27. Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.
Rath JA; Arber C
Cells; 2020 Jun; 9(6):. PubMed ID: 32570906
[TBL] [Abstract][Full Text] [Related]
28. The PMDB Protein Model Database.
Castrignanò T; De Meo PD; Cozzetto D; Talamo IG; Tramontano A
Nucleic Acids Res; 2006 Jan; 34(Database issue):D306-9. PubMed ID: 16381873
[TBL] [Abstract][Full Text] [Related]
29. NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases.
Wang J; Cao Y; Zhang H; Wang T; Tian Q; Lu X; Lu X; Kong X; Liu Z; Wang N; Zhang S; Ma H; Ning S; Wang L
Nucleic Acids Res; 2017 Jan; 45(D1):D902-D907. PubMed ID: 27899613
[TBL] [Abstract][Full Text] [Related]
30. T Cell Receptors for Gene Transfer in Adoptive T Cell Therapy.
Sharma P; Kranz DM
Crit Rev Immunol; 2019; 39(2):105-122. PubMed ID: 31679251
[TBL] [Abstract][Full Text] [Related]
31. T-cell receptor affinity in the age of cancer immunotherapy.
Hoffmann MM; Slansky JE
Mol Carcinog; 2020 Jul; 59(7):862-870. PubMed ID: 32386086
[TBL] [Abstract][Full Text] [Related]
32. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium.
Bagaev DV; Vroomans RMA; Samir J; Stervbo U; Rius C; Dolton G; Greenshields-Watson A; Attaf M; Egorov ES; Zvyagin IV; Babel N; Cole DK; Godkin AJ; Sewell AK; Kesmir C; Chudakov DM; Luciani F; Shugay M
Nucleic Acids Res; 2020 Jan; 48(D1):D1057-D1062. PubMed ID: 31588507
[TBL] [Abstract][Full Text] [Related]
33. CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer.
Tian J; Cai Y; Li Y; Lu Z; Huang J; Deng Y; Yang N; Wang X; Ying P; Zhang S; Zhu Y; Zhang H; Zhong R; Chang J; Miao X
Nucleic Acids Res; 2021 Jan; 49(D1):D1065-D1073. PubMed ID: 33010176
[TBL] [Abstract][Full Text] [Related]
34. T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road.
Crowther MD; Svane IM; Met Ö
Cells; 2020 Jun; 9(7):. PubMed ID: 32630096
[TBL] [Abstract][Full Text] [Related]
35. Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy.
Aversa I; Malanga D; Fiume G; Palmieri C
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235561
[TBL] [Abstract][Full Text] [Related]
36. TCR-like antibodies in cancer immunotherapy.
He Q; Liu Z; Liu Z; Lai Y; Zhou X; Weng J
J Hematol Oncol; 2019 Sep; 12(1):99. PubMed ID: 31521180
[TBL] [Abstract][Full Text] [Related]
37. NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability.
Sommermeyer D; Conrad H; Krönig H; Gelfort H; Bernhard H; Uckert W
Int J Cancer; 2013 Mar; 132(6):1360-7. PubMed ID: 22907642
[TBL] [Abstract][Full Text] [Related]
38. Avidity characterization of genetically engineered T-cells with novel and established approaches.
Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
[TBL] [Abstract][Full Text] [Related]
39. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
40. TCRdb: a comprehensive database for T-cell receptor sequences with powerful search function.
Chen SY; Yue T; Lei Q; Guo AY
Nucleic Acids Res; 2021 Jan; 49(D1):D468-D474. PubMed ID: 32990749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
